Divergent roles for RalA and RalB in malignant growth of human pancreatic carcinoma cells.
about
RalA-exocyst complex regulates integrin-dependent membrane raft exocytosis and growth signalingGeranylgeranyltransferase I inhibitors target RalB to inhibit anchorage-dependent growth and induce apoptosis and RalA to inhibit anchorage-independent growthEmerging roles for the non-canonical IKKs in cancerThe tumor suppressor PP2A Abeta regulates the RalA GTPaseDistinct roles of RalA and RalB in the progression of cytokinesis are supported by distinct RalGEFs.Tuberous sclerosis tumor suppressor complex-like complexes act as GTPase-activating proteins for Ral GTPasesNovel therapeutic targets for pancreatic cancerActivation of the RalGEF/Ral pathway promotes prostate cancer metastasis to boneCancer of the Pancreas: Molecular Pathways and Current Advancement in TreatmentGenetics and biology of pancreatic ductal adenocarcinomaThe Key Role of Calmodulin in KRAS-Driven AdenocarcinomasRas superfamily GEFs and GAPs: validated and tractable targets for cancer therapy?Long-Term ERK Inhibition in KRAS-Mutant Pancreatic Cancer Is Associated with MYC Degradation and Senescence-like Growth Suppression.Ral GTPase down-regulation stabilizes and reactivates p53 to inhibit malignant transformationRal GTPases: crucial mediators of exocytosis and tumourigenesisRal GTPases in tumorigenesis: emerging from the shadowsAberrant overexpression of the Rgl2 Ral small GTPase-specific guanine nucleotide exchange factor promotes pancreatic cancer growth through Ral-dependent and Ral-independent mechanismsIdentification and characterization of mechanism of action of P61-E7, a novel phosphine catalysis-based inhibitor of geranylgeranyltransferase-ISynthesis of novel Ral inhibitors: An in vitro and in vivo studyThe Interplay between Oncogenic Signaling Networks and Mitochondrial Dynamics.Ral-Arf6 crosstalk regulates Ral dependent exocyst trafficking and anchorage independent growth signallingDiscovery and characterization of small molecules that target the GTPase RalRal-regulated interaction between Sec5 and paxillin targets Exocyst to focal complexes during cell migration.The Ral GTPase pathway in metastatic bladder cancer: key mediator and therapeutic targetPhosphorylation of RalB is important for bladder cancer cell growth and metastasisRalBP1 is necessary for metastasis of human cancer cell linesMass spectroscopic phosphoprotein mapping of Ral binding protein 1 (RalBP1/Rip1/RLIP76).Pancreatic cancer.Ras effector switching promotes divergent cell fates in C. elegans vulval patterning.Myo1c regulates lipid raft recycling to control cell spreading, migration and Salmonella invasionSH3BP1, an exocyst-associated RhoGAP, inactivates Rac1 at the front to drive cell motility.RalB regulates contractility-driven cancer dissemination upon TGFβ stimulation via the RhoGEF GEF-H1IKK is a therapeutic target in KRAS-Induced lung cancer with disrupted p53 activity.Ras oncogene-independent activation of RALB signaling is a targetable mechanism of escape from NRAS(V12) oncogene addiction in acute myeloid leukemia.A novel approach to tag and identify geranylgeranylated proteins.Ral activation promotes melanomagenesis.Oncogenic KRAS signalling in pancreatic cancer.Cyclin-dependent kinase inhibitor Dinaciclib (SCH727965) inhibits pancreatic cancer growth and progression in murine xenograft modelsThe cytoplasmic deacetylase HDAC6 is required for efficient oncogenic tumorigenesis.TLN-4601 suppresses growth and induces apoptosis of pancreatic carcinoma cells through inhibition of Ras-ERK MAPK signaling.
P2860
Q22001510-EEA2267F-9B0F-4EA6-88B5-EC37916F9FEBQ24294230-89F95C50-864F-4421-A20A-36D468C5D48AQ24305225-14C54664-828A-4891-83C2-9C55365C06B7Q24307546-5260A5D5-4836-47DA-B967-EB13B338282EQ24337038-B3E961D9-8A8A-4667-997E-A1BD6126D18EQ24337797-CBC13AB6-6F25-43C2-8714-EF83F206F109Q24564267-FAD7878F-21F2-4E0B-8C0A-EF791D0EB1EEQ24681479-A1D67266-27DD-40B5-A95C-0CDA45270815Q26740619-9B3BAB39-8B4C-4CB0-8211-98C422285E64Q26765438-E7C042E3-07D3-46A7-9578-30DDD9958EA7Q27021883-03045142-6DF3-45D2-8EB0-4832298AD56FQ27690752-10A8D95E-F2C2-4E05-A956-4758B190C703Q27853310-B9AB83D0-36B8-4C0A-872F-2E14A5F667C3Q28247699-7FAC5443-C697-46E1-953A-CE3AFACDF2B7Q28259292-8FA1856A-4E62-4B66-9F76-1C6FCB1C2AF0Q28294053-DFCA0347-3E2B-4F60-A80E-ED7DA8EDBE40Q28384212-8041C385-9009-4390-9C90-8E5E0B0256C2Q28477527-EC4A88FA-92E3-4994-9B14-9A0F401971CAQ28817036-A8AC36DD-43CB-42C9-9777-E0679434A13DQ30252391-8FAAE74B-195B-4A94-B1E2-9212F84CDFB6Q30276654-F9FFE01E-4414-482C-9E7E-3701C1139A58Q30366783-5A803887-CEC7-4B63-A074-E79D05C0E598Q30393951-A0570974-F9B5-44A5-8818-5311834474A1Q30415154-48A258F3-4ECC-4EFA-B46D-7E8A74B3BF13Q30429890-436AEF1D-05ED-4DB8-A3E0-AD18B91645D5Q30433862-EA66BF91-9046-484E-81B0-2360E60131BDQ30439679-D57F247F-0936-4BE6-A98E-88C450E9BA8DQ30490247-8C9C3CD4-3F85-48B1-8447-6CCD651B4CA8Q30498007-7953FB68-CE42-4788-82A8-1DB673BD305AQ30514215-E8BC700C-793C-48DB-9E23-D15BDDEE2A2EQ30527901-87183BBE-4D40-41FA-A4AC-1CA4DAC63367Q30657060-54A64B11-9B75-48DD-8AC0-ED8EC7F86163Q33776852-C226BB17-F1B5-45D9-B16A-C065A342E8CEQ33779805-1C573AD9-A574-4BB5-8EEE-1F3945F4D4D6Q33791208-B01BE13D-09CC-4398-9211-A55D212BA4FBQ34086528-0AD5391A-E3F4-4AC9-A7B0-689CFB7413B6Q34113460-D1DB0898-D3DA-4597-8B02-3C47DAE8E983Q34201623-3BB11C07-837F-45EE-BAC1-495E0CB33C60Q34296908-341DB392-9F54-4643-B005-F6BDBAA21291Q34344787-F78A1E8C-F298-4E37-B66C-DA2F28899C83
P2860
Divergent roles for RalA and RalB in malignant growth of human pancreatic carcinoma cells.
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Divergent roles for RalA and R ...... an pancreatic carcinoma cells.
@ast
Divergent roles for RalA and R ...... an pancreatic carcinoma cells.
@en
Divergent roles for RalA and R ...... an pancreatic carcinoma cells.
@nl
type
label
Divergent roles for RalA and R ...... an pancreatic carcinoma cells.
@ast
Divergent roles for RalA and R ...... an pancreatic carcinoma cells.
@en
Divergent roles for RalA and R ...... an pancreatic carcinoma cells.
@nl
prefLabel
Divergent roles for RalA and R ...... an pancreatic carcinoma cells.
@ast
Divergent roles for RalA and R ...... an pancreatic carcinoma cells.
@en
Divergent roles for RalA and R ...... an pancreatic carcinoma cells.
@nl
P2093
P1433
P1476
Divergent roles for RalA and RalB in malignant growth of human pancreatic carcinoma cells
@en
P2093
Channing J Der
Christopher M Counter
Kevin O'Hayer
Paul M Campbell
S Disean Kendall
Stacey J Adam
P304
P356
10.1016/J.CUB.2006.10.023
P407
P577
2006-12-01T00:00:00Z